PRTK
Paratek Pharmaceuticals Inc
Price:  
2.23 
USD
Volume:  
4,755,429.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRTK EV/EBITDA

-833.0%
Upside

As of 2024-05-22, the EV/EBITDA ratio of Paratek Pharmaceuticals Inc (PRTK) is -7.74. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRTK's latest enterprise value is 343.47 mil USD. PRTK's TTM EBITDA according to its financial statements is -44.39 mil USD. Dividing these 2 quantities gives us the above PRTK EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.2x - 17.2x 14.2x
Forward P/E multiples 14.5x - 20.8x 18.3x
Fair Price (15.02) - (17.10) (16.35)
Upside -773.6% - -866.6% -833.0%
2.23 USD
Stock Price
(16.35) USD
Fair Price

PRTK EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA